Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

BD Biosciences

BD Biosciences
2004 FOUNDED
M&A STATUS
41-50 EMPLOYEES
M&A LATEST DEAL TYPE
$205M LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer of an analytical flow cytometer. The company provides a bench-top cell and bead analysis system for life science researchers; CFlow software for accessing flow cytometry; CSampler, an automated flow cytometry; reagents and kits; and accessories.

Formerly Known As
Accuri Cytometers
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Software
Primary Office
  • 173 Parkland Plaza
  • Ann Arbor, MI 48103
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore BD Biosciences’s full profile, request a free trial.

BD Biosciences Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 07-Feb-2011 $205M 000.00 00000 Completed Generating Revenue
5. Later Stage VC (Series E) 12-Jul-2010 000 000.00 000.00 Completed Generating Revenue
4. Later Stage VC (Series D) 13-Jul-2009 000 000.00 000.00 Completed Startup
3. Later Stage VC (Series C) 08-Jul-2008 0000 000.00 000.00 Completed Startup
2. Early Stage VC (Series B) 17-Apr-2007 $5.2M $5.2M 0000 Completed Startup
1. Early Stage VC (Series A) 01-Feb-2005 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

BD Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series E 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series D 00,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series C 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B 20,958,739 $0.000010 $0.02 $0.25 $0.25 1x $0.25 16.73%
Series A 15,471,493 $0.000010 $0.05 $0.39 $0.39 1x $0.31 15.54%
To view this company’s complete Cap Table, request access »

BD Biosciences Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 0000000000 27-Feb-2017 000000000000000000 Discovery Tools (Healthcare)
Adaptive Biotechnologies 06-May-2015 Later Stage VC 00000 Biotechnology
To view this company’s complete investment and acquisition history, request access »

BD Biosciences Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000000 000000000 06-May-2015 00000 00000 00 00000 Completed
  • 13 buyers
To view this company’s complete exits history, request access »

BD Biosciences Subsidiaries (1)

Company Name Industry Location Founded
00000 0000000000 Discovery Tools (Healthcare) Los Angeles, CA 0000
To view this company’s complete subsidiary history, request access »

BD Biosciences Former Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Amherst Fund Venture Capital Minority 000 0000 000000 0
Arboretum Ventures Venture Capital Minority 000 0000 000000 0
Baird Capital PE/Buyout Minority 000 0000 000000 0
Credit Suisse Investment Bank Minority 000 0000 000000 0
F-Prime Capital Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »

BD Biosciences Executive Team (5)

Name Title Board
Seat
Contact
Info
Jeffrey Williams President & Chief Executive Officer
Linda McAllister Ph.D Vice President, Scientific Affairs
Ger van den Engh Ph.D Vice President

2 Former Executives

You’re viewing 3 of 5 executives. Get the full list »